Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T18:46:54.657Z.
Calculation as of: 2026-10-06T18:46:54.657Z.
Quote observation: 2026-10-06T18:43:32.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: fc2e94c8beea8e322b310e9b25a1b89028fd55b2fc6a2790cf1d230843e32158
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Incannex Healthcare Limited
Market Cap
$37.59M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$38.11M
Operating Cash Flow Yield
N/A
TTM Avg
4.07%
3Y Avg
3.32%
5Y Avg
3.32%
Market Cap
$38.52M
Operating Cash Flow Yield
1.68%
TTM Avg
21.41%
3Y Avg
13.95%
5Y Avg
10.59%
Market Cap
$36.70M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$36.23M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$39.15M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$36.28M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$35.86M
Operating Cash Flow Yield
N/A
TTM Avg
0.20%
3Y Avg
0.20%
5Y Avg
0.20%
Market Cap
$35.57M
Operating Cash Flow Yield
N/A
TTM Avg
53.98%
3Y Avg
44.70%
5Y Avg
26.51%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Incannex Healthcare Limited (IXHL) | $37.59M | N/A | N/A | N/A | N/A |
| Nephros, Inc. (NEPH)vs › | $38.11M | N/A | 4.07% | 3.32% | 3.32% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.52M | 1.68% | 21.41% | 13.95% | 10.59% |
| Edesa Biotech, Inc. (EDSA)vs › | $36.70M | N/A | N/A | N/A | N/A |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.23M | N/A | N/A | N/A | N/A |
| Metagenomi, Inc. Common Stock (MGX)vs › | $39.15M | N/A | N/A | N/A | N/A |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.28M | N/A | N/A | N/A | N/A |
| EUDA Health Holdings Limited (EUDA)vs › | $35.86M | N/A | 0.20% | 0.20% | 0.20% |
| DocGo Inc. (DCGO)vs › | $35.57M | N/A | 53.98% | 44.70% | 26.51% |
| Veru Inc. (VERU)vs › | $40.21M | N/A | 0.02% | 0.02% | 0.25% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
